Thursday 1/26
I have recommendations for vax comms, too:
- Talk about the risks by risk category, particularly age and sex.
- Explain why US policy is so unlike that of European countries
- Talk about Number Needed to Vaccinate for various outcomes such as serious illness, ICU admission, and death. Compare that with vax risks.
- Talk about excess death and why it hasn't normalized.
- Explain why vax-related RCTs haven't continued, having been replaced by much weaker observational studies.
- Explain how CDC/VRBAC/ACIP are getting reformed to eliminate the catastrophically bad performance since 2020.
I have recommendations for vax comms, too:
- Talk about the risks by risk category, particularly age and sex.
- Explain why US policy is so unlike that of European countries
- Talk about Number Needed to Vaccinate for various outcomes such as serious illness, ICU admission, and death. Compare that with vax risks.
- Talk about excess death and why it hasn't normalized.
- Explain why vax-related RCTs haven't continued, having been replaced by much weaker observational studies.
- Explain how CDC/VRBAC/ACIP are getting reformed to eliminate the catastrophically bad performance since 2020.
I have recommendations for vax comms, too:
- Talk about the risks by risk category, particularly age and sex.
- Explain why US policy is so unlike that of European countries
- Talk about Number Needed to Vaccinate for various outcomes such as serious illness, ICU admission, and death. Compare that with vax risks.
- Talk about excess death and why it hasn't normalized.